Cargando…
Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer
Although immune checkpoint inhibitors have shown improvement in survival in comparison to chemotherapy in urothelial bladder cancer, many patients still fail to respond to these treatments and actual efforts are made to identify predictive factors of response to immunotherapy. Understanding the tumo...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492984/ https://www.ncbi.nlm.nih.gov/pubmed/31069145 http://dx.doi.org/10.1080/2162402X.2019.1581556 |